Citation: J. Moreb et al., ARE INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR-ALPHA PROTECTIVE AGAINST 4-HYDROPEROXYCYCLOPHOSPHAMIDE TOXICITY, Cancer research, therapy & control, 5(4), 1998, pp. 237-239
Authors:
ANDERSSON BS
MARTINKA S
MCWILLIAMS K
HAI T
MOLLDREM J
BRUTON J
GIAN V
FERNANDEZ H
TARANTOLO S
KASHYAP A
FORMAN SJ
HU W
BLUME K
CAGNONI P
JONES R
CHAMPLIN RE
Citation: Bs. Andersson et al., THERAPY WITH IV BUSULFAN, CYTOXAN (BUCY) AND ALLOGENEIC HEMATOPOIETICSTEM-CELLS (HSC) FOR ADVANCED HEMATOLOGICAL MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 333-333
Citation: D. Mann et al., FAILURE OF INTRAVENOUS RIBAVIRIN IN THE TREATMENT OF INVASIVE ADENOVIRUS INFECTION FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION - A CASE-REPORT, The Journal of infection, 36(2), 1998, pp. 227-228
Authors:
ANDERSSON BS
HAI T
MADDEN T
CAGNONI P
JONES R
BRUTON J
MARTINKA S
HOLBERT K
GIRALT S
PRZEPIORKA D
LENNON S
SPILKER B
GIAN V
WINGARD J
TARANTOLO S
KASHYAP A
FORMAN S
CHAMPLIN RE
Citation: Bs. Andersson et al., ALLOGENEIC TRANSPLANTATION IN ADVANCED HEMATOLOGIC MALIGNANCIES AFTER-IV BUSULFAN CYCLOFOSFAMIDE (BUCY), Blood, 90(10), 1997, pp. 1003-1003
Authors:
MOREB J
ITURRASPE J
MYERS L
YOUNGBLOOD M
KANARR C
HUTCHESON C
GIAN V
BRAYLAN R
Citation: J. Moreb et al., THE USE OF MINIMAL LEUKAPHERESIS PROCEDURES FOR AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IS COST-EFFECTIVE, Blood, 86(10), 1995, pp. 3945-3945